PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Biomarkers may help ID treatment of acute kidney injury

In a matter of hours or days, a hospitalized person's kidneys might start to fail as a reaction to medication or result of sepsis

2023-05-23
(Press-News.org) Hospital inpatients who develop an acute kidney injury (AKI) generally fare poorly after being discharged, and have few options for effective treatment.  

A UW Medicine-led study published recently in American Journal of Kidney Diseases suggests that new tests might improve this narrative.

In the study, “about 30% of the patients that came into the hospital developed AKI, which means in a matter of hours or days, their kidneys might be failing because of reaction to drugs or contracting sepsis,” said lead author Dr. Pavan Bhatraju, an assistant professor of pulmonary and critical care medicine at the University of Washington School of Medicine.

Causes of AKI vary. For instance, sepsis, medication and inadequate blood supply in someone who is undergoing cardiac bypass are all potential causes of kidney injury. It’s also the case that, within the kidneys, different cell types can be injured in the process of AKI, said Dr. Jonathan Himmelfarb, a professor of nephrology at the UW School of Medicine and the study’s senior author.

“The way that we diagnose acute kidney injury today relies on a simple blood test of kidney function or a change in urine output,” Himmelfarb said. “These relatively crude diagnostic tools don’t detect the specific cause of injury or predict which individuals will be more likely to respond to a treatment or recover kidney function.”

Unfortunately, effective medical therapies do not exist for this population of patients, Bhatraju said. In their paper, the investigators proposed a way to classify subpopulations of AKI patients with the aim of identifying therapies specific patient populations.  

In much the same way that distinct biomarkers inform treatments of subgroups of patients with cancer or asthma, so, too, could blood- and urine-based biomarkers help identify subgroups of patients with AKI, leading to new ideas for treatments, the authors said.

In the study, the researchers retrospectively analyzed 769 patients with AKI and 769 without the condition, and followed them for five years after hospital discharge. The researchers found two molecularly distinct AKI subgroups, or sub-phenotypes, that were associated with differing risk profiles and long-term outcomes.

Patients in one group had higher rates of congestive heart failure, while another group had higher rates of chronic kidney disease and sepsis, Bhatraju said. The patients in the second group also had a 40% higher risk for major adverse kidney events five years later, compared with the first group, he said.

Interestingly, Bhatraju added, age, sex, diabetes rate or major surgical procedure as the cause of AKI was not different across AKI subgroups. This finding suggests that commonly measured clinical factors may not predict the AKI subgroups, and that identification requires measurement of blood and urine biomarkers, he said.

“We’re attempting to better understand the clinical factors and molecular drivers of acute kidney injury so that, in the long run, we can better treat the different ways that people experience this disease process,” Himmelfarb added. “We want to better understand the individual characteristics of people who get acute kidney injury so we can establish common characteristics of subgroup populations of these patients to know whose risk is relatively higher or lower, and work toward treatments specific to their needs.

“Our paper is one step on the path to tailoring clinical trials of new therapies to the people who are most likely to respond to those therapies,” Himmelfarb said.  

This study was supported by the supplemental American Recovery and Reinvestment Act funds through the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health (grants U01DK082223, U01DK082185, U01DK082192, U01DK082183, U01DK084012 and R01DK098233) and by the NIH (K23DK116967, R01DK133177, U2CDK114886, UG3TR002158, and U01DK099923).

END


ELSE PRESS RELEASES FROM THIS DATE:

nTIDE May 2023 Deeper Dive: How did COVID-19 lockdown impact employment of individuals with visual disabilities?

nTIDE May 2023 Deeper Dive: How did COVID-19 lockdown impact employment of individuals with visual disabilities?
2023-05-23
East Hanover, NJ – May 23, 2023 – New data show that while individuals with visual disabilities were slow to recover employment because of the effects of the COVID-2019 lockdown, they have made headway, depending on their level of disability, almost meeting their pre-pandemic levels. Possible reasons for their slower recovery include major safety concerns due to the shortage of personal protective equipment, less access to vaccines, and their vulnerability to severe consequences of COVID, according to experts speaking during last Friday’s nTIDE Deeper Dive Lunch & Learn Webinar. Using data from the U.S. Bureau of Labor Statistics (BLS) for persons ages 16-64, the ...

Few adult smokers and nonsmokers think e-cigarettes have lower levels of harmful chemicals than cigarettes

2023-05-23
About half of cigarette smokers and young adult non-smokers think that nicotine-based electronic cigarettes have the same amount or even more harmful chemicals than regular tobacco-based cigarettes, according to a Rutgers study.   The study, published in Addiction, measured perceived levels of harmful chemicals in e-cigarettes compared with cigarettes using national samples of more than 1,000 adults ages 18 and older who smoke cigarettes and 1,000-plus adults ages 18 to 29 who are nonsmokers. The study also measured associations with e-cigarette/cigarette relative harm perceptions, e-cigarette use and interest. About 20 percent of all participants ...

Capturing transporter structure paves the way for drug development

Capturing transporter structure paves the way for drug development
2023-05-23
(Memphis, Tenn.—May 23, 2023) Scientists at St. Jude Children’s Research Hospital and the University of Texas Southwestern Medical Center studied the structure and function of a transporter involved in cancer and immunity. They captured six structures of the transporter, including when it was bound to an inhibitor, providing unprecedented insight into how it works. The findings, published in Cell, have implications for drug development.   Transporters escort substances across the cell membrane so that they can carry out their functions. Sphingosine-1-phosphate (S1P) is an important signaling molecule that regulates the immune system, blood vessel formation, auditory ...

Did dome-headed dinosaurs sport bristly headgear?

Did dome-headed dinosaurs sport bristly headgear?
2023-05-23
If you look at enough dinosaur fossils, you'll see that their skulls sport an amazing variety of bony ornaments, ranging from the horns of Triceratops and the mohawk-like crests of hadrosaurs to the bumps and knobs covering the head of Tyrannosaurus rex. But paleontologists are increasingly finding evidence that dinosaurs had even more elaborate head ornaments not preserved with the fossil skulls — structures made of keratin, the stuff of fingernails, that were likely used as visual signals or semaphores to others of their kind. A newly described species of dome-headed dinosaur — a pachycephalosaur ...

Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics launch the Lupus Landmark Study to accelerate personalized treatments in lupus

2023-05-23
NEW YORK, NY (May 23) – The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics today announced the launch of the Lupus Landmark Study, a groundbreaking observational research study to accelerate the development of personalized treatments for people living with lupus. The Lupus Landmark Study, the largest study of its kind in lupus, will prospectively recruit and longitudinally follow 3,500 adults diagnosed with systemic lupus erythematosus (SLE). The Lupus Landmark Study is a ...

The severity of sleep apnea may be underestimated in Black patients

The severity of sleep apnea may be underestimated in Black patients
2023-05-23
Session:  C110, Advanced Signal Analysis: New Diagnostics and Physiologic Insights for SDB (sleep-disordered breathing) Date and Time: 2:15 p.m. ET, Tuesday, May 23, 2023 Location:  WEWCC, Room 144 A-C (Street Level)   ATS 2023, Washington, DC – Obstructive sleep apnea (OSA) tests may underestimate the severity of OSA in Black patients, according to research published at the ATS 2023 International Conference.   Recent research with ICU patients during the COVID-19 pandemic showed that pulse oximeters—clip-like devices that are attached to a fingertip to measure blood oxygen ...

Strategic city planning can help reduce urban heat island effect

2023-05-23
UNIVERSITY PARK, Pa. — The tendency of cities to trap heat — a phenomenon called the “urban heat island,” often referred to as the UHI effect — can lead to dangerous temperatures in the summer months, but new Penn State research suggests that certain urban factors can reduce this effect. The study found that trees had a cooling effect on outdoor air temperature, mean radiant temperature and predicted mean vote index, a measurement designed to evaluate thermal comfort levels. Additionally, the researchers determined that higher building-height-to-street-width ratios — when taller ...

The aging mouse prostate: kinetics of lymphocyte infiltration

The aging mouse prostate: kinetics of lymphocyte infiltration
2023-05-23
“This dataset presents the most comprehensive profiling of the aging adult mouse prostate immune profile to date.” BUFFALO, NY- May 23, 2023 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 9, entitled, “Highly multiplexed immune profiling throughout adulthood reveals kinetics of lymphocyte infiltration in the aging mouse prostate.” Aging is a significant risk factor for disease in several tissues, including the prostate. Defining the kinetics ...

Organizations must go beyond medical views on menopause to support women’s professional aspirations - study

2023-05-23
Organisations must enable mid-life women to thrive in the workplace by taking inspiration from societies such as China and Japan to encourage positive conversations around the impact of menopause, a new study reveals. But as they support older women in pursuing their ambitions and accessing career opportunities, organisations must ensure they do not hinder career progression through overlooked promotions, undervalued work, and lost opportunities. In Western countries, the menopause is traditionally viewed as a managed medical condition that creates physiological challenges which women must overcome if they are to function as effectively in the workplace ...

Insomnia drug class may not influence death and exacerbation risks among patients with COPD

Insomnia drug class may not influence death and exacerbation risks among patients with COPD
2023-05-23
Session:  C98, Risky Business: Predicting Consequences of OSA Date and Time: 2:51 p.m. ET, Tuesday, May 23, 2023 Location:  Marriott Marquis Washington, Independence Ballroom, Salons E-H (Level M4)   ATS 2023, Washington, DC – Chronic obstructive pulmonary disease patients newly prescribed non-benzodiazepine benzodiazepine receptor agonists (NBZRAs) such as zolpidem (Ambien, Intermezzo and other brands), a class of hypnotic drugs prescribed for insomnia, did not have an increased risk of exacerbations requiring hospitalizations or of death than those prescribed ...

LAST 30 PRESS RELEASES:

Unveiling the mysteries of cell division in embryos with timelapse photography

Survey finds loneliness epidemic runs deep among parents

Researchers develop high-energy-density aqueous battery based on halogen multi-electron transfer

Towards sustainable food systems: global initiatives and innovations

Coral identified as oldest bioluminescent organism, suggesting a new model of ancient ecology

SRI chosen by DARPA to develop next-generation computational design of metallic parts and intelligent testing of alloys

NJIT engineers muffle invading pathogens with a 'molecular mask'

Perinatal transmission of HIV can lead to cognitive deficits

The consumption of certain food additive emulsifiers could be associated with the risk of developing type 2 diabetes

New cancer research made possible as Surrey scientists study lipids cell by cell 

Bioluminescence first evolved in animals at least 540 million years ago

Squids’ birthday influences mating

Star bars show Universe’s early galaxies evolved much faster than previously thought

Critical minerals recovery from electronic waste

The move by Apple Memories to block potentially upsetting content illustrates Big Tech’s reach and limits, writes Chrys Vilvang

Chemical tool illuminates pathways used by dopamine, opioids and other neuronal signals

Asian monsoon lofts ozone-depleting substances to stratosphere

PET scans reveal ‘smoldering’ inflammation in patients with multiple sclerosis

Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors

Health information on TikTok: The good, the bad and the ugly

New study points to racial and social barriers that block treatment for multiple myeloma

Rensselaer researcher finds that frog species evolved rapidly in response to road salts

A new chapter in quantum vortices: Customizing electron vortex beams

Don’t be a stranger – study finds rekindling old friendships as scary as making new ones

There’s no ‘one size fits all’ when it comes to addressing men’s health issues globally

Comparison of the “late catch-up” phenomenon between BuMA Supreme and XIENCE stents through serial optical coherence tomography at 1–2 month and 2 year follow-ups: A multicenter study

Marine plankton communities changed long before extinctions

Research reveals tools to make STEM degrees more affordable

Q&A: UW research shows neural connection between learning a second language and learning to code

Keane wins 2024 Gopal K. Shenoy Excellence in Beamline Science Award

[Press-News.org] Biomarkers may help ID treatment of acute kidney injury
In a matter of hours or days, a hospitalized person's kidneys might start to fail as a reaction to medication or result of sepsis